HighPoint Advisor Group LLC Buys New Holdings in Roche Holding AG (OTCMKTS:RHHBY)

HighPoint Advisor Group LLC purchased a new position in Roche Holding AG (OTCMKTS:RHHBY) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 10,288 shares of the company’s stock, valued at approximately $373,000.

A number of other large investors have also bought and sold shares of RHHBY. Saratoga Research & Investment Management boosted its holdings in shares of Roche by 1.4% during the fourth quarter. Saratoga Research & Investment Management now owns 2,300,436 shares of the company’s stock worth $83,345,000 after purchasing an additional 31,957 shares during the period. Pacer Advisors Inc. grew its position in shares of Roche by 1,937.5% in the 4th quarter. Pacer Advisors Inc. now owns 1,099,659 shares of the company’s stock worth $39,841,000 after buying an additional 1,045,687 shares during the last quarter. OLD National Bancorp IN increased its stake in shares of Roche by 2.0% during the third quarter. OLD National Bancorp IN now owns 251,843 shares of the company’s stock valued at $8,619,000 after buying an additional 4,956 shares during the period. Hikari Power Ltd raised its holdings in shares of Roche by 0.8% during the fourth quarter. Hikari Power Ltd now owns 237,820 shares of the company’s stock valued at $8,616,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Altrius Capital Management Inc lifted its stake in Roche by 2.9% in the fourth quarter. Altrius Capital Management Inc now owns 176,001 shares of the company’s stock worth $6,377,000 after acquiring an additional 4,939 shares during the period.

Roche Price Performance

Shares of Roche stock opened at $35.22 on Friday. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $40.15. The company has a current ratio of 1.35, a quick ratio of 1.04 and a debt-to-equity ratio of 0.75. The company has a 50-day moving average of $31.77 and a 200 day moving average of $33.25.

Analyst Ratings Changes

A number of research analysts have issued reports on RHHBY shares. The Goldman Sachs Group assumed coverage on shares of Roche in a report on Thursday, May 30th. They issued a “sell” rating for the company. Deutsche Bank Aktiengesellschaft raised shares of Roche from a “sell” rating to a “hold” rating in a research note on Friday, May 17th. Finally, Argus reaffirmed a “hold” rating on shares of Roche in a research report on Monday, March 4th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $40.00.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.